このエピソードについて
In Part 2 of the premiere of our RxP oral history podcast, Dr. Mario Marquez shares his experiences and insights as one of the first prescribing psychologists in the United States. He discusses the challenges he faced, the evolution of prescribing psychology in New Mexico, and the importance of building relationships with legislators to navigate the complexities of prescribing regulations. Dr. Marquez emphasizes the need for psychologists to utilize a comprehensive approach to treatment, advocating for a balance between medication and therapeutic interventions.
英語
アメリカ合衆国
文字起こし 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
このポッドキャストの他のエピソード
Dr. George Kapalka and Dr. Glenn Ally continue their conversation on the evolution of prescriptive authority for psychologists in Louisiana, highlighting the challenges faced, the relationships built, and the legislative efforts that led to significant changes in the field. Dr. Ally shares personal…
Dr. George Kapalka speaks with two central figures in the early development of psychopharmacology training for psychologists outside the military: Dr. Elaine LeVine and Dr. Stephen Berger. The conversation traces the origins and evolution of the Prescribing Psychologist Register (PPR), founded by D…
In the premiere episode of our oral history podcast on the history of psychopharmacology, Dr. George Kapalka interviews Dr. Mario Marquez, a pioneer in prescribing psychology. They discuss the history and evolution of the RxP movement, particularly in New Mexico, where the first legislation allowin…
In this look at The Continuing Evolution and History of RxP, Alliant MSCP program director Dr. George Kapalka interviews Dr. Glenn Ally, a pioneer of the RxP movement in Louisiana. In Part 1 of their conversation, they discuss movement’s history, the political landscape surrounding the legislation,…
免責: このページに埋め込まれているポッドキャストとアートワークは Alliant University からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。
